Author
Listed:
- Rezk R. Ayyad
(Pharmaceutical Medicinal Chemistry Department, Faculty of Pharmacy, Hilla University, Babylon, Iraq)
- Yasser Abdel Allem Hassan
(Pharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, Al-Kitab University, Kirkuk, Iraq)
- Ahmed G. El-Dahshan
(Ministry of Health, Arab Republic of Egypt)
- Mennah G. El-Dahshan
(Ministry of Health, Arab Republic of Egypt)
- Sherif G. El-Dahshan
(Ministry of Health, Arab Republic of Egypt)
- Ahmed R. Ayyad
(Faculty of Medicine, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan)
Abstract
Prodrugs depend on enzymatic processes, essentially in the liver, but can also occur in other tissues to release the active metabolite. These metabolic biotransformations are often enzymatically controlled, ensuring the drug becomes pharmacologically active at its site of action. Metabolism may occur at the target site (e.g., in viruses, where drugs are phosphorylated) or in the liver or other tissues. For example, codeine is activated by demethylation to morphine, which is a more active analgesic than codeine. Clopidogrel oxidized to 2-oxoclopidogrel which is active and 2-oxoclopidogrel which is metabolized in two active thiol metabolite. Enalapril is a prodrug that is metabolized to enalaprilat, the active form. L-Dopa is a prodrug that is converted into dopamine in the brain by decarboxylation. Azathioprine is metabolized to mercaptopurine, which is immunosuppressive. Sulfasalazine is a prodrug metabolized by azoreductase and converted to 5-aminosalicylic acid and sulfapyridine, which are more active than sulfasalazine. Prontosil is a prodrug converted into sulfanilamide, which is more active than prontosil. Salicin is a glycoside that is metabolized into salicylic acid, which is active as an analgesic. Valacyclovir is metabolized into acyclovir, which is an active antiviral.
Suggested Citation
Rezk R. Ayyad & Yasser Abdel Allem Hassan & Ahmed G. El-Dahshan & Mennah G. El-Dahshan & Sherif G. El-Dahshan & Ahmed R. Ayyad, 2026.
"Activation of Prodrugs Depend on the Metabolism of These Prodrugs,"
Current Research in Medical Sciences, Paradigm Academic Press, vol. 5(2), pages 1-10, March.
Handle:
RePEc:bdz:curmsc:v:5:y:2026:i:2:p:1-10
DOI: 10.63593/CRMS.2026.03.01
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bdz:curmsc:v:5:y:2026:i:2:p:1-10. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Editorial Office (email available below). General contact details of provider: https://www.paradigmpress.org/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.